All entries for: CELLeBRAIN Co., Ltd.

February 27, 2026

CELLeBRAIN Co., Ltd.

Orphan Drug Designation

Jeonju-si
1-50 employees

treatment of malignant glioma

Disease Area: Rare Diseases
Scroll to Top